FDA Investigator Yen Tso Kuo

Yen Tso Kuo has conducted inspections on 75 sites in 1 countries as of 04 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
75
Last Inspection Date:
04 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Yen Tso Kuo:
Aimee K Contreras, Alex G Kalugin, Alexandra B Pitkin, Alexandra M Cossi, Ali Hernandez, Amanda N Schaupp, Andrew B Slarve, Angel K Sandhu, Angela Shepas, Angelica Ornelas, Anna L Marroquin, Anna L Viveros Hernandez, Ashar P Parikh, Bonnie I Needleman, Breena L D'ambrogi, Brian R Henderson, Brian Ravitch, Bruce D Broidy, Bruce R Burrell, Burnsb, Carey A Watson, Carl Lee, Carrie E Thrasher, Cathleen A Carr Sharpe, Cathryn M Groehnert, CDR Rochelle B Young, RPh, MSA, Celena Ngo, Chloe Anne Leong, Christine M Parmentier, Christopher D Washington, Christopher J Lee, Christopher M Jenner, Cindy W Lewis, Courtney R Bolton, Cristina Resendiz Navarrete, Damon A Growl, Daniel C Geffin, Daniel J Roberts, Daniel Velasquez, Darrin E Davis, David G Eng, David G Whitman, David Y Hernandez, Davis, Deborah W Hsu, Debra J Fracassa, Doan T Nguyen, PharmD, Edna J Hidalgo, Eileen T Dupont, Elaine S Chow, Elizabeth C Ajuzie, Elodie X Tong Lin, Emal Wahab, Eric W Anderson, Estefania Fernandez, Frank P Bianco, Gabriel Craig, Garrad R Poole, Geoffrey M Leist, Grace P Santos, Greg K Keshishyan, Gulshan R Anand, Gunneet Kaur, Helen J Hamaoka, Henry E Carrillo, Herminio C Francisco, Hunter M Vice, Ingrid A Zambrana, Irma D Padilla, Jacqueline O Snell, James A Barreto, James P Stallings, Jane G Choi, Janice M Loy, Janice Wai, Jazmine M Welcher, Jeff M Uriarte, Jeffrey W Shrifter, DPM, Jennifer Crumb, Jennifer L Degroot, Jennifer L Johnson, Joanne M Fukuda, Joey V Quitania, John A Liu, Jonathan K Dare, Jorge L Bertran, Joseph C Yen, Joseph H Lam, Joseph Tibay, Juan A Morales, Judy C Nepsa, Julia Ventura, Ka L Wong, Kacie M Crowther, Karen D Phung, Karen J Bak, Karla J Gibler, Kelley, Kelvin X Sanders, Kevin Lee, Kevin T Gerrity, Kimberly M Lichter, Kimiko G Casuga, Kristin M Abaonza, Larkin R Buckalew, Leonard H Lavi, Lija V Fellows, Lilly O Barton, Liming Zhang, Linda S Shook, Lorraine N Williams, LT Mark A Chen, MPH, Lydia S Chan, Mabel M Lee, Marco A Solorio, Margo C Jones, Maridali Deleon Torres, Mark Gray, Mark I Nakano, Mary C Acton, Mary C Wall, Matthew A Walburger, Matthew J Johnson, Maxyne T Lam, Mcgrewp, Megan E Kulas, Michael D Garcia, Michael S Araneta, Michael S Call, Muoi N Hoang, Natalie J Ayoub, Natalie J Reese, Naveen B Walker, Ngoc B Kelsch, Ngoc T Le, Nianna C Burns, Nicole Yuen, Nympha V Florendo, Patricia F Alberico, Phal K Chhun, Phillip J Sample, Phung, Quynh H Strandberg, Raphelia Spisso, Richard W Tubb, Robert C Hoover, Rochelle A Rolnik, Rocio Guzman Velazquez, Romero, Ronald P Boyce, Rumany C Penn, PharmD, Ryan J Borges, Saied A Asbagh, Sara Jdent Acosta, Savannah E Samp, Scott J Matsuda, Scott N Lim, Sean P Desbrow, Shaquenta Y Perkins, Sonia R Peterson, Sparky L Bartee, Stacie A Woods, Steven J Branch, Steven M Galvez, Sundy V Sedwick, Sydney S Taylor, Taichun Qin, PhD, Tammy Vasquez Hancock, Tanya E Malais, Tara L Stockton, Thomas W Gordon, Timothy C Grome, Timothy P Lafave, Trushani T Desai, Uttaniti Limchumroon (Tom), Vanessa R Muller, Ve T Vuong, Victoria L Morgan, Virgilio F Pacio, CSO, Wayne L Jefferson, Wen Jun Peng, Wendy S Antonowsky, William J Leonard, William J Weis, Yolanda D Mitchell Lee, Yvette Mlacour Davis, Yvonne T Lacour, Zachary A Bogorad, Zachary Ryan Harris

Yen Tso Kuo's Documents

Publish Date Document Type Title
April, 2024 FDA 483 Avatar Foods Inc - Form 483, 2024-04-29
May, 2022 FDA 483 Grimmway Enterprises, Inc. dba Grimmway Farms - Form 483, 2022-05-04
October, 2023 FDA 483 Sol-ti Inc. - Form 483, 2023-10-05
July, 2023 FDA 483 Cali Rice Valley, Inc. - Form 483, 2023-07-08

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more